Bank of America Issues Positive Forecast for Option Care Health (NASDAQ:OPCH) Stock Price

Option Care Health (NASDAQ:OPCH) had its price target upped by Bank of America from $32.00 to $35.00 in a research note published on Tuesday,Benzinga reports. They currently have a buy rating on the stock.

Several other research firms have also recently weighed in on OPCH. TD Cowen decreased their price target on shares of Option Care Health from $30.00 to $27.00 and set a “hold” rating on the stock in a report on Monday, November 3rd. Barrington Research restated an “outperform” rating and set a $38.00 target price on shares of Option Care Health in a research report on Friday, October 31st. Morgan Stanley initiated coverage on Option Care Health in a research note on Friday, October 17th. They issued an “overweight” rating and a $35.00 target price on the stock. Cowen began coverage on Option Care Health in a research report on Thursday, October 2nd. They set a “hold” rating for the company. Finally, JMP Securities set a $36.00 price objective on Option Care Health in a report on Friday, October 31st. Ten equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $35.90.

Option Care Health Price Performance

OPCH stock opened at $32.22 on Tuesday. The firm has a 50 day moving average of $28.41 and a 200-day moving average of $29.29. The company has a current ratio of 1.56, a quick ratio of 1.05 and a debt-to-equity ratio of 0.85. Option Care Health has a 12 month low of $22.29 and a 12 month high of $35.53. The firm has a market capitalization of $5.11 billion, a P/E ratio of 25.57, a price-to-earnings-growth ratio of 2.16 and a beta of 0.79.

Insider Buying and Selling

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. purchased 38,000 shares of the firm’s stock in a transaction on Monday, November 3rd. The shares were purchased at an average cost of $25.98 per share, with a total value of $987,240.00. Following the completion of the purchase, the director owned 413,390 shares of the company’s stock, valued at $10,739,872.20. The trade was a 10.12% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 0.64% of the stock is owned by insiders.

Institutional Trading of Option Care Health

Several hedge funds have recently added to or reduced their stakes in OPCH. US Bancorp DE increased its holdings in shares of Option Care Health by 5.0% in the first quarter. US Bancorp DE now owns 8,199 shares of the company’s stock worth $287,000 after buying an additional 393 shares during the period. Charles Schwab Investment Management Inc. grew its position in Option Care Health by 4.0% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 2,609,705 shares of the company’s stock worth $91,209,000 after acquiring an additional 99,574 shares during the last quarter. Townsquare Capital LLC purchased a new position in Option Care Health in the 1st quarter worth approximately $692,000. Virtu Financial LLC purchased a new position in Option Care Health in the 1st quarter worth approximately $1,159,000. Finally, Nuveen LLC bought a new stake in Option Care Health in the first quarter valued at approximately $70,965,000. 98.05% of the stock is owned by institutional investors.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.